BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Oxcarbazepine

A carbamazepine derivative that acts as a voltage-gated sodium channel blocker. It is used for the treatment of PARTIAL SEIZURES with or without secondary generalization. It is also an inducer of CYTOCHROME P-450 CYP3A4.

296+ PubMed studies analyzed · 21 RCTs · Evidence Score: 50.8

Research Domains

Oxcarbazepine has been studied across 18 research domains including 😴 Sleep, 💊 Pain, 🫁 Liver & Detox, 🧘 Stress & Anxiety, 🌤️ Mood & Depression. The primary research focus is 😴 Sleep with 13% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Oxcarbazepine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Latanoprost
3 shared targets
Metronidazole
3 shared targets
nafadotride
3 shared targets
Artemether
3 shared targets
Rosmarinic
5 shared targets
Nortriptyline
4 shared targets
3',4'-didemethylnobiletin
2 shared targets
Ezetimibe
4 shared targets
Niridazole
3 shared targets
Nisoldipine
9 shared targets
Loading evidence profile...

This evidence profile for Oxcarbazepine is generated deterministically from 296 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.